Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.-论文-万方医学网

第一作者： Justin,Stebbing

第一单位： Department of Surgery and Cancer, Imperial College, London, UK.

作者： Justin,Stebbing ^[1] ; Venkatesh,Krishnan ^[2] ; Stephanie,de Bono ^[2] ; Silvia,Ottaviani ^[1] ; Giacomo,Casalini ^[3] ; Peter J,Richardson ^[4] ; Vanessa,Monteil ^[5] ; Volker M,Lauschke ^[5] ; Ali,Mirazimi ^[5] ; Sonia,Youhanna ^[5] ; Yee-Joo,Tan ^[6] ; Fausto,Baldanti ^[7] ; Antonella,Sarasini ^[7] ; Jorge A Ross,Terres ^[2] ; Brian J,Nickoloff ^[2] ; Richard E,Higgs ^[2] ; Guilherme,Rocha ^[2] ; Nicole L,Byers ^[2] ; Douglas E,Schlichting ^[2] ; Ajay,Nirula ^[2] ; Anabela,Cardoso ^[2] ; Mario,Corbellino ^[8] ; Sacco Baricitinib Study Group

作者单位： Department of Surgery and Cancer, Imperial College, London, UK. ^[1] Eli Lilly and Company, Indianapolis, IN, USA. ^[2] Luigi Sacco, Department of Clinical and Biomedical Sciences, University of Milan, Milan, Italy. ^[3] BenevolentAI, London, UK. ^[4] Unit of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.;Department of Physiology and Pharmacology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. ^[5] Infectious Diseases Programme, Immunology Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.;Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore. ^[6] Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy.;Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[7] Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy. ^[8]

医学主题词成年人(Adult);老年人(Aged);抗病毒药(Antiviral Agents);人工智能(Artificial Intelligence);吖丁啶类(Azetidines);冠状病毒感染(Coronavirus Infections);细胞因子类(Cytokines);药物评价, 临床前(Drug Evaluation, Preclinical);药物重新定位(Drug Repositioning);女(雌)性(Female);人类(Humans);细胞内信号肽和蛋白质类(Intracellular Signaling Peptides and Proteins);白细胞(Leukocytes);肝(Liver);男(雄)性(Male);中年人(Middle Aged);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘌呤类(Purines);吡唑类(Pyrazoles);球形体, 细胞(Spheroids, Cellular);磺胺类(Sulfonamides)

DOI 10.15252/emmm.202012697

PMID 32473600

发布时间 2025-05-30

检索历史清除

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

EMBO molecular medicine

相似文献

同项目论文

EMBO molecular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

EMBO molecular medicine

相似文献

同项目论文

EMBO molecular medicine

相关期刊

检索历史清除